Sotera Health Company beat EPS estimates 69% of the time across 16 reported quarters (11 beats, 5 misses), averaging +3.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.22 | $0.24 | +9.1% | Beat | Q2 FY26 call |
| Q1 FY26 | $0.15 | $0.14 | -6.7% | Miss | |
| Q4 FY25 | $0.22 | $0.23 | +4.5% | Beat | |
| Q3 FY25 | $0.20 | $0.24 | +20.0% | Beat | |
| Q2 FY25 | $0.15 | $0.18 | +20.0% | Beat | Q2 FY25 call |
| Q1 FY25 | $0.10 | $0.12 | +20.0% | Beat | |
| Q4 FY24 | $0.19 | $0.19 | +0.0% | Beat | |
| Q3 FY24 | $0.17 | $0.14 | -17.6% | Miss | |
| Q2 FY24 | $0.15 | $0.17 | +13.3% | Beat | |
| Q1 FY24 | $0.12 | $0.11 | -8.3% | Miss | |
| Q4 FY23 | $0.24 | $0.24 | +0.0% | Beat | |
| Q3 FY23 | $0.20 | $0.18 | -10.0% | Miss |
Back to SHC overview · SHC holders · SHC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.